One of the top fundraisers of 2024 is halving its workforce about a year after drawing in a $325 million series C. Cell therapy biotech Arsenal Biosciences has laid off about 50% of its staff as it ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

The BIO campaign warns that decreased funding could hamper both current patient care and the future pipeline of medical breakthroughs. By featuring documentary-style stories of researchers and ...

Danaher Corporation’s DHR Biotechnology segment continues to be a major contributor to its growth. In the first quarter of ...

This new book by the National Research Council recommends that the government expand existing regulations and rely on self-governance by scientists rather than adopt intrusive new policies. One key ...

Novo Nordisk's move to end its work in cell therapy is part of new CEO Maziar Mike Doustdar’s initiative aimed at saving around $1.3 billion annually by the end of 2026. (iStock / Getty Images Plus) ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Behind the scenes of Southern ...

The majority of Americans do not live in a biotech hub. Yet 62 percent of all U.S. biopharma venture investment occurs in Massachusetts and California, according to Pitchbook, while 77 percent of ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Biotech Labz Supply has announced an exciting expansion of its product line, focusing on research peptides that are gaining attention in the scientific community. As a leading supplier of high-quality ...